Edwards Lifesciences Corporation
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
Asset Breakdown FY2012
Total Assets: $2.22B
Liabilities Breakdown FY2012
Total Liabilities: $754.4M
Asset Breakdown
Total Assets: $2.22B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $310.9M | 14.0% |
| Accounts Receivable | $321.1M | 14.5% |
| Inventory | $281.0M | 12.6% |
| Property, Plant & Equipment | $373.3M | 16.8% |
| Goodwill | $384.7M | 17.3% |
| Intangible Assets | $67.0M | 3.0% |
| Other Assets | $483.5M | 21.8% |
Liabilities Breakdown
Total Liabilities: $754.4M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $74.7M | 9.9% |
| Long-Term Debt | $189.3M | 25.1% |
| Other Liabilities | $490.4M | 65.0% |